These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7185559)

  • 21. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I; Niebauer G
    Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluorescence microscopy demonstration of porphyrins in bone tissue in porphyria cutanea tarda. Comparative in vivo studies on liver function tests, liver histology and porphyrin excretion].
    Czitober H; Schnack H; Wewalka F
    Dtsch Med Wochenschr; 1967 Sep; 92(39):1761-7. PubMed ID: 6054338
    [No Abstract]   [Full Text] [Related]  

  • 25. Porphyria cutanea tarda.
    Khoo BP; Tay YK
    Singapore Med J; 2000 Jun; 41(6):292-4. PubMed ID: 11109347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings].
    Okolicsanyi L; Orlando R; Busnardo F; Naccarato R; Veller-Fornasa C; Polin R
    Clin Ter; 1980 Sep; 94(6):687-94. PubMed ID: 7460503
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxychloroquine treatment of porphyria cutanea tarda.
    Malkinson FD; Levitt L
    Arch Dermatol; 1980 Oct; 116(10):1147-50. PubMed ID: 7425660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The porphyrias.
    Sekula SA; Tschen JA; Rosen T
    Am Fam Physician; 1986 Mar; 33(3):219-32. PubMed ID: 3513498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porphyria cutanea tarda symptomatica in children treated with chloroquine. Report of four cases with control liver biopsies.
    Tamayo L; Ruiz-Maldonado R; Ridaura C
    J Dermatol; 1985 Aug; 12(4):329-40. PubMed ID: 3910689
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanism of bullous formation in porphyria cutanea tarda. 1. Histopathological observation of bullae in 3 cases of porphyria cutanea tarda].
    Nagato N; Ohgami T; Murayama F; Honda T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1987 Mar; 97(4):471-7. PubMed ID: 3613213
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 32. [The sclerovitiliginous form of porphyria cutanea tarda].
    Verbenko EV; Snarskaia ES; Ezhov NIa
    Vestn Dermatol Venerol; 1990; (2):75-7. PubMed ID: 2343675
    [No Abstract]   [Full Text] [Related]  

  • 33. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

  • 34. Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.
    Timonen K; Niemi KM; Mustajoki P
    Clin Exp Dermatol; 1991 Sep; 16(5):355-8. PubMed ID: 1794189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Porphyria cutanea tarda as an occupational disease].
    Wozniak KD
    Berufsdermatosen; 1972; 20(4):159-65. PubMed ID: 4262759
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
    Malina L; Chlumský J
    Acta Derm Venereol; 1981; 61(4):346-50. PubMed ID: 6173993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels.
    Friedman SJ; Doyle JA
    J Am Acad Dermatol; 1985 Jul; 13(1):70-4. PubMed ID: 4031154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E; Besrat A; Damtew B; Seyoum E; Landells JW
    Trans R Soc Trop Med Hyg; 1981; 75(3):401-4. PubMed ID: 7324107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.